Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.
Colorectal Neoplasms
DRUG: tezacitabine|DRUG: oxaliplatin
The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.